Baricitinib, a drug commonly used by people with rheumatoid arthritis, reduced hospitalized COVID19 patients’ risk of dying by 13% when taken with other proven COVID-19 drugs.
. Now, baricitinib reduces deaths even further. “This is a drug that is just as effective as tocilizumab,” Landray says. “The effect size is very similar.”
But the rise of the Omicron variant of SARS-CoV-2 has also challenged progress in treating COVID-19. Several antibody treatments are ineffective against this variant, which now dominates infections across the globe. In its recent guideline update, WHO recommended that an antibody cocktail, casirivimab-imdevimab, only be given when a different variant has caused an infection.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: Four more Covid-related deaths and 477 hospital casesThe total number of deaths linked to the virus reported by Stormont's Department of Health is 3,217.
Read more »
Covid-19: Three more Covid-related deaths and 483 hospital casesThe total number of deaths linked to the virus reported by Stormont's Department of Health is 3,220.
Read more »
Utah reports 461 new COVID-19 cases, 19 deathsThe Utah Department of Health reported 461 new cases of COVID-19 on Wednesday, a fraction of the number of cases reported during the omicron variant surge in January and early February.
Read more »
NFL suspends all COVID-19 protocolsThe NFL and NFL Players Association have agreed to suspend all aspects of the joint COVID-19 protocols.
Read more »
Ivermectin, condemned by experts as COVID-19 treatment, continues to be easily accessible through telemedicineDespite warnings from major health institutions, some telehealth services are providing easy access to unproven drugs for the treatment of COVID-19.
Read more »
NFL, NFLPA Announce Immediate Suspension of COVID-19 ProtocolsThe NFL and NFLPA announced the league is suspending their joint COVID-19 protocols “effective immediately”
Read more »